PMID: 8581395Oct 1, 1995Paper

Monitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease status

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
G Buccheri, D Ferrigno

Abstract

The tissue polypeptide antigen (TPA) is a protein produced and released by proliferating cells that possesses several characteristics for an ideal tumor marker. Our purpose was to define the clinical yield of TPA in the follow-up of patients with lung cancer (LC). Three hundred and forty-one new LC patients underwent an extensive pre-treatment staging evaluation (UICC 1987 classification) and a TPA serum measurement. We restaged them at regular times by: 1, clinical history and physical examination, routine lab tests, chest X-rays, and any other examination as suggested by the prior baseline evaluation, and 2, the serum level of TPA. We evaluated a total of 1513 assays (including 1172 posttreatment measurements). Individual values of TPA correlated significantly with treatment response and disease status. Patients with small-cell lung cancer showed the lowest correlation indexes between clinical parameters and the marker. Each objective response to treatment or disease progression was almost always associated to consistent changes of TPA (P < 0.0001, by the Wilcoxon's test). A 50% reduction under the prior TPA value was 30% sensitive, 90% specific, and 88% accurate in the diagnosis of response to treatment. The same percent red...Continue Reading

References

Oct 6, 1975·The American Journal of Cardiology·R S Galen
Jan 1, 1983·Acta Chemica Scandinavica. Series B: Organic Chemistry and Biochemistry·B Lüning, U Nilsson
Jan 1, 1981·Cancer·A B MillerA Winkler
Oct 1, 1993·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·G BuccheriF Vola
Jan 1, 1994·The European Respiratory Journal·D FerrignoA Biggi
Jan 1, 1954·Annual Review of Biochemistry·A C GRIFFIN
Jan 1, 1957·International Archives of Allergy and Applied Immunology·B BJORKLUND, V BJORKLUND
Jan 1, 1958·International Archives of Allergy and Applied Immunology·B BJORKLUNDV BJORKLUND

❮ Previous
Next ❯

Citations

Oct 1, 1995·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T A Splinter
Sep 29, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·G BuccheriUNKNOWN Cuneo Lung Cancer Study Group
Nov 27, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·G Buccheri, D Ferrigno
Mar 1, 1997·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·A HamzaouiJ P Kleisbauer
Mar 21, 2002·Expert Review of Molecular Diagnostics·G Buccheri, D Ferrigno
Oct 29, 2002·British Journal of Cancer·G Buccheri, D Ferrigno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.